Skip to main content
    P

    Pyxis Oncology Inc (PYXS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.41
    -0.17 (-10.76%)

    Market Cap: $188.98M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Pyxis Oncology Inc (PYXS) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Pyxis Oncology (PYXS) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Pyxis Oncology reported EPS of -$0.24, above the -$0.27 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    52%(11/21)
    Avg Surprise
    -31.02%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.23
    Range-$0.30 - -$0.16
    11 analysts
    Revenue Consensus
    $19.83K
    RangeN/A
    11 analysts
    Reports May 12, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.21
    Range-$0.29 - -$0.16
    4 analysts
    EPS Revisions
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.25+14.3%
    60d ago-$0.23+8.6%
    30d ago-$0.23+8.6%
    7d ago-$0.23+8.6%
    Current-$0.21
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Next Report

    PYXS has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, PYXS beat 11 and missed 10. The widest gap in the table came in the quarter ended Dec 31, 2021, when EPS landed 435.14% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.24-$0.27-$0.36 - -$0.22+11.11%BeatN/A9N/ANov 5, 2026N/A
    Jun 30, 2026-$0.40-$0.34-$0.40 - -$0.29-17.65%MissN/A91 up, 1 downAug 13, 2026$389000
    Mar 31, 2026-$0.37-$0.35-$0.42 - -$0.29-5.71%MissN/A92 up, 3 downMay 14, 2026$631000
    Dec 31, 2025-$0.29-$0.33-$0.39 - -$0.29+11.83%BeatN/A91 up, 6 downMar 23, 2026$9.15M
    Sep 30, 2025-$0.35-$0.34-$0.37 - -$0.27-2.94%MissN/A74 up, 2 downNov 3, 2025$684000
    Jun 30, 2025-$0.30-$0.35-$0.36 - -$0.34+14.29%BeatN/A60 up, 3 downAug 14, 2025$2.82M
    Mar 31, 2025-$0.35-$0.29-$0.32 - -$0.26-20.69%MissN/A30 up, 0 downMay 15, 2025$515000
    Dec 31, 2024-$1.32-$0.32-$0.38 - -$0.28-312.50%MissN/A71 up, 4 downMar 18, 2025N/A
    Sep 30, 2024-$0.35-$0.31-$0.35 - -$0.29-12.90%MissN/A60 up, 0 downNov 12, 2024$705000
    Jun 30, 2024-$0.29-$0.33-$0.37 - -$0.27+12.12%BeatN/A70 up, 0 downAug 14, 2024$708000
    Mar 31, 2024-$0.06-$0.24-$0.34 - -$0.12+75.00%BeatN/A60 up, 0 downMay 14, 2024$16.95M
    Dec 31, 2023-$0.33-$0.47-$0.57 - -$0.35+29.79%BeatN/A60 up, 0 downMar 21, 2024$576000
    Sep 30, 2023-$0.56-$0.51-$0.63 - -$0.44-9.80%MissN/A30 up, 0 downNov 7, 2023$598000
    Jun 30, 2023-$0.41-$0.66-$0.74 - -$0.61+37.88%BeatN/A40 up, 0 downAug 11, 2023$564000
    Mar 31, 2023-$0.55-$0.90-$1.08 - -$0.79+38.89%BeatN/A40 up, 0 downMay 11, 2023$38000
    Dec 31, 2022-$1.04-$1.01-$1.17 - -$0.81-2.97%MissN/A40 up, 0 downMar 22, 2023N/A
    Sep 30, 2022-$0.85-$0.89-$0.96 - -$0.67+4.49%BeatN/A40 up, 0 downNov 1, 2022N/A
    Jun 30, 2022-$0.79-$0.92-$1.00 - -$0.51+14.13%BeatN/A40 up, 0 downAug 15, 2022N/A
    Mar 31, 2022-$0.97-$0.50-$0.73 - -$0.43-94.00%MissN/A40 up, 0 downMay 13, 2022N/A
    Dec 31, 2021-$1.98-$0.37-$0.54 - -$0.37-435.14%MissN/A40 up, 1 downMar 29, 2022N/A
    Sep 30, 2021-$0.45-$0.52-$8.97 - -$0.23+13.46%BeatN/A4N/AOct 8, 2021N/A
    Jun 30, 2021-$1.02N/AN/AN/AN/AN/AN/AN/ASep 1, 2021N/A
    Mar 31, 2021-$15.93N/AN/AN/AN/AN/AN/AN/AJun 30, 2021N/A
    Dec 31, 2020-$15.93N/AN/AN/AN/AN/AN/AN/AMar 31, 2021N/A
    Mar 31, 2020-$2.74N/AN/AN/AN/AN/AN/AN/AJun 29, 2020N/A
    Dec 31, 2019-$2.74N/AN/AN/AN/AN/AN/AN/AMar 30, 2020N/A
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.29, after -$2.02 the year before. It was -$2.74 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.29N/A
    Dec 31, 2024-$2.02N/A
    Dec 31, 2023-$1.85N/A
    Dec 31, 2022-$3.65N/A
    Dec 31, 2021-$19.38N/A
    Dec 31, 2020-$18.67N/A
    Dec 31, 2019-$2.74N/A

    Frequently Asked Questions About PYXS

    When is Pyxis Oncology's next earnings date?

    Pyxis Oncology's next earnings report is expected for Mar 22, 2027.

    Did PYXS beat earnings estimates last quarter?

    Yes. Pyxis Oncology reported EPS of -$0.24 for the quarter ended Sep 30, 2026, above the -$0.27 estimate, a 11.11% surprise.

    What EPS do analysts expect from PYXS next quarter?

    The consensus EPS estimate for Pyxis Oncology for the quarter ending Dec 31, 2026 is -$0.23 from 11 analysts, with estimates from -$0.30 to -$0.16.

    How often does PYXS beat earnings estimates?

    Pyxis Oncology beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -40.28%.